FDA Highlights Off-Patent Opportunities

Latest Update To List Of Products Open To Competition With No Rivals

 
• By Dave Wallace

Opportunities for generic competition have been highlighted by the FDA, in the latest update to its list of products that are not protected by patents or exclusivities but have no approved rivals.

Washington, D.C., USA- January 13, 2020: FDA Sign outside their headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
The FDA has published its latest list of off-patent products with no competition • Source: Shutterstock

More from Generics

More from Products